Clinical trials: sponsored by University of Edinburgh
Acute Coronary Syndrome, Coronary Artery Disease
Duration of Dual Anti-Platelet Therapy (DUAL-ACS)
Despite substantial evidence supporting the use of dual anti-platelet therapy in patients with acute coronary syndrome, there remains major uncertainty regarding the optimal duration of therapy.
- Trial name
- NCT03252249
- Testing
- 3 months dual anti-platelet therapy, 12 months dual anti-platelet therapy
- Where
- United Kingdom
- Volunteers
- 5,094 people
- Sponsor
- University of Edinburgh
Paget Disease
Zoledronate In the Prevention of Paget's Disease: Long Term Extension
Paget's disease of the bone (PDB) is a metabolic bone disorder which in some individuals can cause pain, bone deformity, arthritis and deafness, although in many patients it does not cause symptoms.
- Trial name
- ZiPP-LTE (NCT03859895)
- Where
- 21 sites in Australia, Belgium and 5 more
- Volunteers
- 287 people
- Sponsor
- University of Edinburgh
Cardiovascular Diseases, Kidney Transplant; Complications
Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation
Cardiovascular disease (for example, heart attack, stroke, heart failure) is the commonest complication of kidney failure. Kidney transplantation reduces cardiovascular risk but cardiovascular disease remains the commonest cause…
- Trial name
- CRAFT-CTCA (NCT06234410)
- Testing
- Computed tomography coronary angiography (CTCA)
- Where
- 2 sites in United Kingdom
- Volunteers
- 332 people
- Sponsor
- University of Edinburgh
ANCA Associated Vasculitis (AAV)
PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis
Antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) is a severe autoimmune condition characterised by inflammation of small blood vessels.
- Trial name
- PANDA-VASC (NCT07258524)
- Where
- United Kingdom
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- University of Edinburgh
Surgery, Inpatients
EMUs: Enhanced Monitoring Using Sensors After Surgery
Patients can become critically unwell following surgical operations. Delay in recognition of this deterioration can result in patient harm and even death.
- Trial name
- EMUs (NCT06565559)
- Testing
- Wearable Wireless Sensor
- Where
- 17 sites in Benin, Ghana and 6 more
- Volunteers
- 1,332 people
- Sponsor
- University of Edinburgh
Kidney Transplant, Kidney Disease, Chronic
KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection
An observational study capturing real world transplant patients in the post-operative setting aiming to further determine the utility of biomarkers to improve outcomes.
- Trial name
- KTRSensors (NCT06830473)
- Where
- 2 sites in United Kingdom
- Volunteers
- 200 people
- Sponsor
- University of Edinburgh
Acute Heart Failure, Diagnosis
Prospective Validation of the CoDE-HF Algorithm for the Diagnosis of Acute Heart Failure
Acute heart failure is a life-threatening condition where the heart is suddenly unable to pump blood around the body. It can be challenging to diagnose because the symptoms often mimic other conditions.
- Trial name
- ProVa CoDE-HF (NCT05518396)
- Testing
- CoDE-HF decision support tool
- Where
- United Kingdom
- Volunteers
- 3,808 people
- Sponsor
- University of Edinburgh
Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia
Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
Almost all people who have had type 1 diabetes for 5 years have a defect in secretion of the hormone Glucagon. This hormone is involved in the body's response to low blood glucose (hypoglycaemia).
- Conditions
- Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia, Hypoglycemia, Hypoglycemia Unawareness
- Trial name
- NCT04614168
- Testing
- Stepped hyperinsulinaemic-hypoglycaemic clamp study, Insulin pump, Continuous glucose monitor
- Where
- United Kingdom
- Volunteers
- 24 people
- Sponsor
- University of Edinburgh
Takayasu Arteritis, Takayasu Arteritis (TAK)
Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis
This study aims to understand the experiences of patients with Takayasu arteritis (TAK) and how physicians manage the condition.
- Trial name
- TAK-IMPACT (NCT07351422)
- Testing
- Questionnaire
- Where
- United Kingdom
- Volunteers
- 50 people
- Sponsor
- University of Edinburgh
Colon Cancer, Colorectal Cancer
Does Genetic Susceptibility for Bleeding Affect Quantitative Faecal Immunochemical Test (qFIT) Results?
Quantitative faecal immunochemical testing (qFIT) is used to test for blood within faeces that cannot always be visible. The presence of blood in the stool has been shown to be a finding where there may be a problem within the…
- Trial name
- NCT05329870
- Testing
- SNP array
- Where
- United Kingdom
- Volunteers
- healthy volunteers welcome
- Sponsor
- University of Edinburgh
Cachexia
Muscle Wasting in Cancer (MWIC)
One way cancer affects people is through weight loss. During this weight loss (called cachexia), all types of body tissue are lost, but there is a greater rate of muscle loss than fat.
- Trial name
- MWIC (NCT03191955)
- Where
- United Kingdom
- Volunteers
- 282 people, healthy volunteers welcome
- Sponsor
- University of Edinburgh
Lymphoproliferative Disorder
Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation
RATIONALE: Some types of lymphoproliferative disease are associated with Epstein-Barr virus. Combining reduced immunosuppressive therapy with donor white blood cells that have been treated in the laboratory to kill cells infected…
- Trial name
- NCT00033475
- Testing
- therapeutic allogeneic lymphocytes
- Where
- 12 sites in United Kingdom
- Volunteers
- 50 people
- Sponsor
- University of Edinburgh
Cardiovascular Diseases
Computed Tomography Coronary Angiography for the Prevention of Myocardial Infarction (The SCOT-HEART 2 Trial)
It is hypothesised that, in individuals being considered for cardiovascular preventative therapy, computed tomography coronary angiography guided management will reduce the future risk of coronary heart disease death or non-fatal…
- Trial name
- SCOT-HEART 2 (NCT03920176)
- Testing
- Computed tomography coronary angiography, ASSIGN Score
- Where
- United Kingdom
- Volunteers
- 6,139 people
- Sponsor
- University of Edinburgh
Large Vessel Vasculitis, Giant Cell Arteritis (GCA)
Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)
Large vessel vasculitis (LVV) is a disease that causes damage to blood vessels. This damage to blood vessels can increase the risk of patients with LVV developing cardiovascular disease, including heart attacks and strokes.
- Conditions
- Large Vessel Vasculitis, Giant Cell Arteritis (GCA), Takayasu Arteritis
- Trial name
- DERAIL-LVV (NCT06887062)
- Testing
- Bosentan and dapagliflozin
- Where
- United Kingdom
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- University of Edinburgh
Ulcerative Colitis Flare
MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis
This is a Phase 2b, multi-centered, randomized, placebo-controlled trial with treatment phase over 24 weeks. Ulcerative Colitis (UC) is a condition that causes inflammation and ulceration of the inner lining of the rectum and…
- Trial name
- MARVEL (NCT04276740)
- Testing
- MitoQ
- Where
- United Kingdom
- Volunteers
- 79 people
- Sponsor
- University of Edinburgh
Anemia Acute, Fatigue
ABC - A Post Intensive Care Anaemia Management Trial
On discharge from intensive care (ICU) patients are often severely anaemic (have a low level of haemoglobin (Hb) in their red blood cells (RBC)). Anaemia can persist for many months making patients feel tired and fatigued.
- Conditions
- Anemia Acute, Fatigue, Physical Disability, Quality of Life
- Trial name
- NCT04591574
- Testing
- Red Blood Cells (Transfusion)
- Where
- United Kingdom
- Volunteers
- 346 people
- Sponsor
- University of Edinburgh
Ulcerative Colitis
Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis
Mini-MARVEL study, children and young people with an active flare of UC requiring either the start of or an increase in existing mesalazine therapy will be given either MitoQ or placebo as a daily capsule for 24 weeks in the…
- Trial name
- Mini-MARVEL (NCT05539625)
- Testing
- MitoQ
- Where
- United Kingdom
- Sponsor
- University of Edinburgh
Hip Osteoarthritis, Knee Osteoarthritis
Golf After Orthopaedic Surgery: A Longitudinal Follow-up (GOLF) Study
Aims The primary aim of this prospective, multi-centre study is to describe the rates of returning to golf following hip, knee and shoulder arthroplasty in an active golfing population.
- Conditions
- Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis
- Trial name
- NCT05676567
- Where
- United Kingdom
- Volunteers
- 124 people
- Sponsor
- University of Edinburgh
Acute Kidney Injury, Kidney Transplant
MEMRI and Kidney Disease
Acute kidney injury (AKI) is common and costly.1 Although patients who suffer an episode of AKI may recover, many will go on to develop cardiovascular disease and chronic kidney disease (CKD).
- Conditions
- Acute Kidney Injury, Kidney Transplant, Vasculitis, Chronic Kidney Disease(CKD)
- Trial name
- NCT06698614
- Testing
- MRI, Blood tests, Urine tests
- Where
- United Kingdom
- Volunteers
- 120 people
- Sponsor
- University of Edinburgh
Cachexia, Oesophageal Cancer
REVOLUTION Surgery (REVOLUTION Surgery)
Some people with cancer suffer from muscle wasting, lose weight and feel tired. This process, termed cachexia, is a significant problem and can lead to a reduction in both quality and quantity of life.
- Conditions
- Cachexia, Oesophageal Cancer, Gastric Cancer, Pancreatic Cancer
- Trial name
- NCT05642819
- Where
- United Kingdom
- Volunteers
- 200 people
- Sponsor
- University of Edinburgh